Insight Research Development from 2010 to 2026

IMDX Stock   6.51  0.36  5.85%   
Insight Molecular Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 7.2 M in 2026. During the period from 2010 to 2026, Insight Molecular Research Development regression line of annual values had r-squared of  0.74 and arithmetic mean of  6,248,981. View All Fundamentals
 
Research Development  
First Reported
2014-03-31
Previous Quarter
3.3 M
Current Value
3.9 M
Quarterly Volatility
769.2 K
 
Yuan Drop
 
Covid
Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 76 M, as well as many indicators such as Price To Sales Ratio of 18.07, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
  
Build AI portfolio with Insight Stock
Check out the analysis of Insight Molecular Correlation against competitors.

Latest Insight Molecular's Research Development Growth Pattern

Below is the plot of the Research Development of Insight Molecular Diagnostics over the last few years. It is Insight Molecular's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insight Molecular's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Insight Research Development Regression Statistics

Arithmetic Mean6,248,981
Geometric Mean5,673,308
Coefficient Of Variation43.35
Mean Deviation2,237,512
Median6,514,000
Standard Deviation2,709,213
Sample Variance7.3T
Range8.4M
R-Value0.86
Mean Square Error2T
R-Squared0.74
Slope462,663
Total Sum of Squares117.4T

Insight Research Development History

20267.2 M
202511.3 M
20249.8 M
20239.3 M
20227.3 M
2021M
20209.8 M

About Insight Molecular Financial Statements

Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development11.3 M7.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Insight Stock Analysis

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.